Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Soy consumption during menopause.

Bolca S, Bracke M, Depypere H.

Facts Views Vis Obgyn. 2012;4(1):30-7.

2.

Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials.

Taku K, Melby MK, Kurzer MS, Mizuno S, Watanabe S, Ishimi Y.

Bone. 2010 Aug;47(2):413-23. doi: 10.1016/j.bone.2010.05.001. Epub 2010 May 7. Review.

PMID:
20452475
3.

Disposition of soy isoflavones in normal human breast tissue.

Bolca S, Urpi-Sarda M, Blondeel P, Roche N, Vanhaecke L, Possemiers S, Al-Maharik N, Botting N, De Keukeleire D, Bracke M, Heyerick A, Manach C, Depypere H.

Am J Clin Nutr. 2010 Apr;91(4):976-84. doi: 10.3945/ajcn.2009.28854. Epub 2010 Feb 17.

4.

S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.

Virk-Baker MK, Barnes S, Krontiras H, Nagy TR.

Nutr Res. 2014 Feb;34(2):116-25. doi: 10.1016/j.nutres.2013.12.002. Epub 2013 Dec 18.

5.

Determination of the isoflavone composition and estrogenic activity of commercial dietary supplements based on soy or red clover.

Andres S, Hansen U, Niemann B, Palavinskas R, Lampen A.

Food Funct. 2015 Jun;6(6):2017-25. doi: 10.1039/c5fo00308c.

PMID:
26023053
6.
7.

Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.

Levis S, Strickman-Stein N, Doerge DR, Krischer J.

Contemp Clin Trials. 2010 Jul;31(4):293-302. doi: 10.1016/j.cct.2010.03.007. Epub 2010 Mar 15.

8.

Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.

Kostelac D, Rechkemmer G, Briviba K.

J Agric Food Chem. 2003 Dec 17;51(26):7632-5.

PMID:
14664520
9.

Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.

Pawlowski JW, Martin BR, McCabe GP, McCabe L, Jackson GS, Peacock M, Barnes S, Weaver CM.

Am J Clin Nutr. 2015 Sep;102(3):695-703. doi: 10.3945/ajcn.114.093906. Epub 2015 Aug 5.

10.

Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.

Liu ZM, Ho SC, Woo J, Chen YM, Wong C.

Menopause. 2014 Jun;21(6):653-60. doi: 10.1097/GME.0000000000000102.

PMID:
24149925
11.
12.

Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.

van der Velpen V, Geelen A, Hollman PC, Schouten EG, van 't Veer P, Afman LA.

Am J Clin Nutr. 2014 Nov;100(5):1269-77. doi: 10.3945/ajcn.114.088484. Epub 2014 Aug 20.

13.

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

Setchell KD, Brown NM, Lydeking-Olsen E.

J Nutr. 2002 Dec;132(12):3577-84. Review.

14.

Systematic review of soy isoflavone supplements on osteoporosis in women.

Wei P, Liu M, Chen Y, Chen DC.

Asian Pac J Trop Med. 2012 Mar;5(3):243-8. doi: 10.1016/S1995-7645(12)60033-9. Review.

15.

Estrogen receptor-mediated effects of isoflavone supplementation were not observed in whole-genome gene expression profiles of peripheral blood mononuclear cells in postmenopausal, equol-producing women.

van der Velpen V, Geelen A, Schouten EG, Hollman PC, Afman LA, van 't Veer P.

J Nutr. 2013 Jun;143(6):774-80. doi: 10.3945/jn.113.174037. Epub 2013 Apr 24.

16.

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens.

Gong P, Madak-Erdogan Z, Li J, Cheng J, Greenlief CM, Helferich W, Katzenellenbogen JA, Katzenellenbogen BS.

Nucl Recept Signal. 2014 Sep 12;12:e001. doi: 10.1621/nrs.12001. eCollection 2014.

17.
18.

Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.

Mangano KM, Hutchins-Wiese HL, Kenny AM, Walsh SJ, Abourizk RH, Bruno RS, Lipcius R, Fall P, Kleppinger A, Kenyon-Pesce L, Prestwood KM, Kerstetter JE.

Nutr Res. 2013 Dec;33(12):1026-33. doi: 10.1016/j.nutres.2013.08.009. Epub 2013 Sep 18.

19.

Soy isoflavones as safe functional ingredients.

Song WO, Chun OK, Hwang I, Shin HS, Kim BG, Kim KS, Lee SY, Shin D, Lee SG.

J Med Food. 2007 Dec;10(4):571-80. Review.

PMID:
18158825
20.

Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.

Koo J, Cabarcas-Petroski S, Petrie JL, Diette N, White RJ, Schramm L.

BMC Cancer. 2015 Nov 16;15:905. doi: 10.1186/s12885-015-1914-5.

Supplemental Content

Support Center